Filing Details
- Accession Number:
- 0001562180-18-000727
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-02-12 17:26:27
- Reporting Period:
- 2018-02-09
- Accepted Time:
- 2018-02-12 17:26:27
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1100412 | Array Biopharma Inc | ARRY | Pharmaceutical Preparations (2834) | 841460811 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1579824 | M Charles Baum | C/O Array Biopharma Inc. 3200 Walnut Street Boulder CO 80301 | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2018-02-09 | 25,000 | $5.95 | 35,000 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2018-02-09 | 25,000 | $5.13 | 60,000 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2018-02-09 | 50,000 | $16.90 | 10,000 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Disposition | 2018-02-09 | 25,000 | $0.00 | 25,000 | $5.95 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2018-02-09 | 25,000 | $0.00 | 25,000 | $5.13 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2017-10-27 | 2026-10-27 | No | 4 | M | Direct |
| 0 | 2016-10-29 | 2025-10-29 | No | 4 | M | Direct |
Footnotes
- The price reported for these shares is the weighted average sale price. Details of actual prices for shares sold are available from the Issuer upon request.
Billionaire Hedge Funds
